Prolife at Medical Fair Asia 2026: Two Risk Factors. One Intelligent Measurement

From September 9 to 11, 2026, Prolife will take part in Medical Fair Asia 2026 at Marina Bay Sands, Singapore — Southeast Asia’s leading exhibition for medical and healthcare technology. The event brings together healthcare professionals, hospital and pharmacy buyers, distributors, and medical technology companies from across the region and international markets. Prolife exhibits at Booth 2H14.
Prolife at Medical Fair Asia 2026: Two Risk Factors. One Intelligent Measurement

At the centre of the Prolife showcase — Prolife PX7 Premium and the technologies behind a new approach to cardiovascular monitoring.

Blood Pressure and Atrial Fibrillation — Two Leading Risk Factors for Stroke

Hypertension and atrial fibrillation are two leading risk factors for stroke. Prolife brings both into a single blood pressure measurement — cardiovascular monitoring with direct clinical relevance, in one measurement cycle.

Prolife PX7 Premium — One Intelligent Measurement Process

Prolife PX7 Premium integrates the brand’s key technologies into one intelligent measurement process:

🔸AFibra SMART — clinically validated technology for atrial fibrillation detection during cuff inflation

🔸AIm (Artificial Intelligence measurement) — AI-based technology that adapts the inflation level and the number of measurement cycles to each user

🔸ComfortPro — measurement during cuff inflation, approximately 1.5 times faster than a standard measurement protocol

🔸Intelligent Assistant (IA) — guidance that supports correct measurement technique and consistent results

The result is a device that combines blood pressure measurement and AF detection with Swiss engineering, clinical validation, and intelligent technology. This approach reflects the Prolife philosophy: health demands control before risks become threats.

For Distribution Partners: A Market-Ready Product for Southeast Asia

For distribution partners, PX7 Premium arrives fully market-ready — clinical validation, regulatory compliance, and marketing support already in place. Prolife accompanies the partner from contract to first sales: a confident foundation for market entry across Southeast Asia.

At Booth 2H14, the Prolife team will meet current and prospective distribution partners to discuss bringing the brand to new markets. To schedule a meeting in advance, contact us through the Contact Us page at prolife-health.com.

Visit Prolife at Medical Fair Asia 2026

📍  September 9–11, 2026

📍  Marina Bay Sands, Singapore

📍  Booth 2H14

Meet Prolife in Singapore and discover the next step in cardiovascular monitoring.

We measure differently.